Location History:
- Harburg, DE (2007)
- Marburg, DE (2010 - 2018)
Company Filing History:
4 out of 104 
2 out of 7 
1 out of 3,685 
Years Active: 2007-2018
Title: Holger Garn - Innovator in Pharmaceutical Composition
Introduction
Holger Garn is a notable inventor based in Marburg, Germany, holding a total of 8 patents. His research and innovations in the pharmaceutical sector have garnered attention for addressing significant health issues, particularly in relation to allergies and inflammatory disorders.
Latest Patents
His most recent innovations include a pharmaceutical composition designed to protect against allergies and inflammatory disorders. This invention focuses on a composition that incorporates naturally occurring, non-transgenic isolated bacteria, which serves as a medicament for the prevention and treatment of allergic or chronic inflammatory conditions.
Another significant patent involves a dermatological and pharmaceutical composition suitable for oligonucleotides. This invention addresses the topical application of oligonucleotides, especially antisense-oligonucleotides including DNAzymes, siRNAs, asDNAs, or ribozymes, as agents against inflammatory diseases through emulsions that contain a dispersed aqueous phase.
Career Highlights
Throughout his career, Holger Garn has been affiliated with notable companies like Mead Johnson Nutrition Company and Sterna Biologicals GmbH & Co. KG. His work in these organizations has allowed him to contribute significantly to the field of pharmaceuticals, enhancing product formulations and therapeutic strategies.
Collaborations
Holger Garn has collaborated with distinguished coworkers, including Harald Renz and Udo Herz. These partnerships have fostered an environment of shared knowledge and expertise, further advancing the innovations that Holger has brought to fruition.
Conclusion
In conclusion, Holger Garn stands out as an influential inventor whose contributions have made a considerable impact on health-related innovations. His work with bacteria-based compositions and oligonucleotides addresses critical issues in modern medicine, positioning him as a key figure in the advancement of pharmaceutical innovations.